Journal of Surgery Concepts & Practice ›› 2018, Vol. 23 ›› Issue (03): 221-226.doi: 10.16139/j.1007-9610.2018.03.009
• Experts forum • Previous Articles Next Articles
Received:2018-02-01
Published:2020-07-25
CLC Number:
| [1] Aljiffry M, Abdulelah A, Walsh M, et al.Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature[J]. J Am Coll Surg,2009,208(1):134-147. [2] Poultsides GA, Zhu AX, Choti MA, et al.Intrahepatic cholangiocarcinoma[J]. Surg Clin North Am,2010,90(4):817-837. [3] Lin XH, Luo JC.The risk factors and prognostic factors of intrahepatic cholangiocarcinoma[J]. J Chin Med Assoc,2017,80(3):121-122. [4] Nakano M, Ariizumi SI, Yamamoto M.Intrahepatic cholangiocarcinoma[J]. Semin Diagn Pathol,2017,34(2):160-166. [5] Spolverato G, Ejaz A, Kim Y, et al.Tumor size predicts vascular invasion and histologic grade among patients undergoing resection of intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg,2014,18(7):1284-1291. [6] Spolverato G, Kim Y, Ejaz A, et al.Conditional probabi-lity of long-term survival after liver resection for intrahe-patic cholangiocarcinoma: a multi-institutional analysis of 535 patients[J]. JAMA surgery,2015,150(6):538-545. [7] Doussot A, Groot-Koerkamp B, Wiggers JK, et al.Outcomes after resection of intrahepatic cholangiocarcinoma: external validation and comparison of prognostic models[J]. J Am Coll Surg,2015,221(2):452-461. [8] Edge SB, Compton CC.The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol,2010, 17(6):1471-1474. [9] Nathan H, Aloia TA, Vauthey JN, et al.A proposed sta-ging system for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol,2009,16(1):14-22. [10] de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahe-patic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment[J]. J Clin Oncol,2011,29(23):3140-3145. [11] Farges O, Fuks D, Le Treut YP, et al.AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group[J]. Cancer,2011, 117(10):2170-2177. [12] Igami T, Ebata T, Yokoyama Y, et al.Staging of peri-pheral-type intrahepatic cholangiocarcinoma: appraisal of the new TNM classification and its modifications[J]. World J Surg,2011,35(11):2501-2509. [13] Spolverato G, Vitale A, Cucchetti A, et al.Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?[J]. Cancer,2015,121(22):3998-4006. [14] Si A, Li J, Xiang H, et al.Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma[J]. Oncotarget,2017,8(27):44521-44532. [15] Kang SH, Hwang S, Lee YJ, et al.Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma[J]. J Hepatobiliary Pancreat Sci,2018,25(4):240-248. [16] Uno M, Shimada K, Yamamoto Y, et al.Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass[J]. Surg Today,2012,42(12):1189-1194. [17] Guglielmi A, Ruzzenente A, Campagnaro T, et al.Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection[J]. World J Surg,2009,33(6):1247-1254. |
| [1] | ZHANG Jixiang, XIE Zhihua, LI Wei, JIANG Xiaoqing. Classification of intrahepatic cholangiocarcinoma and hot topics in surgical treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 478-482. |
| [2] | YIN Yanjiang, LUO Zhiwen, CHEN Xiao, ZHANG Yefan, HUANG Zhen, ZHAO Hong, ZHAO Jianjun, LI Zhiyu, ZHOU Jianguo, CAI Jianqiang, BI Xinyu. Relationship between surgical margin and prognosis of patients with intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 221-228. |
| [3] | CHEN Congyan, WANG Junqing, CHEN Yongjun. Gut microbiota and mechanism of liver cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(3): 256-260. |
| [4] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 93-94. |
| [5] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 95-99. |
| [6] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 100-106. |
| [7] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 107-112. |
| [8] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 113-118. |
| [9] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 119-122. |
| [10] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 123-127. |
| [11] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 128-130. |
| [12] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 131-133. |
| [13] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 134-138. |
| [14] | . [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 139-144. |
| [15] | ZHANG Xihao, ZHANG Xinyun, CAO Manqing, ZHANG Jinliang, WANG Huaqi, ZHANG Su, FU Zhou, WANG Lu, ZHANG Ti. Both anti-angiogenesis and immunotherapy combined with interventional therapy in treatment of hepatocellular carcinoma: effect of hepatic artery infusion chemotherapy compared with hepatic artery chemoembolization [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 152-157. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
